The presence of heparin-platelet factor 4 antibodies as a marker of hypercoagulability during hemodialysis

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 1, 2002, Pages 21-26

  Yu, Anna ^a   Jacobson, Stefan H ^a   Bygdén, Anette ^a   Egberg, Nils ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

Albumin; C reactive protein; ELISA; Heprain induced thrombocytopenia; Platelets; Thrombocytopenia

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; HEPARIN; HEPARIN LEO; IMMUNOGLOBULIN; SERUM ALBUMIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; BLEEDING; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; DISEASE MARKER; DRUG EXPOSURE; FEMALE; HEMODIALYSIS; HUMAN; HYPERCOAGULABILITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOEMBOLISM; THROMBOSIS; UREMIA; VASCULAR ACCESS; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BLOOD PLATELETS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FACTOR 4; RENAL DIALYSIS; THROMBOPHILIA; THROMBOSIS;

PANTHERA;

EID: 0036191125     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.005     Document Type: Article

References (18)

1. Antibodies to macromolecular platelet factor 4-heparin complexed in heparin-induced thrombocytopenia: A study of 44 cases
2. Identification of binding site for heparin and other polysulfated glycoaminoglycans on human thrombocytes
3. Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia - A case report
4. Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis
5. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells
6. Intra-platelet factor 4 (IP. PF4) and the heparin-mobilisable pool of PF4 in health and arteriosclerosis
7. Heparin-associated thrombocytopenia: The antibody is not heparin specific
8. Pathogenicity of IgG and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia
9. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia
10. Fundamental concepts in the pathobiology of heparin-induced thromocytopenia
11. Mechanism of venous and arterial thrombosis in heparin-induced thrombocytopenia
12. Heparin-induced thrombocytopenia in hemodialysis patients
13. The presence of antibodies against a PF4-heparin complex in patients on haemodialysis
14. Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis
15. Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients
16. Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis
17. A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery
18. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia